Completed PHASE4 INTERVENTIONAL 2-arm NCT03793751

Effect of Intraoperative Dexmedetomidine on Early Postoperative Cognitive Dysfunction

Effect of Intraoperative Dexmedetomidine Infusion on Early Postoperative Cognitive Dysfunction (POCD) in Geriatric Patients Undergoing Hip Surgery Under Spinal Anaesthesia

Sponsor: Tata Main Hospital

Conditions Cognitive Dysfunction

Interventions Dexmedetomidine Injection

Updated 10 times since 2019 Last updated: Sep 10, 2024 Started: Oct 1, 2017 Primary completion: Dec 1, 2019 Completion: Dec 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03793751, this PHASE4 trial focuses on Cognitive Dysfunction and remains completed. Sponsored by Tata Main Hospital, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Oct 2024 — Present [monthly]

Completed PHASE4
Sep 2024 — Oct 2024 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE4
May 2020 — Jan 2021 [monthly]

Completed PHASE4
Apr 2020 — May 2020 [monthly]

Completed PHASE4
Jan 2020 — Apr 2020 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Feb 2019 — Jan 2020 [monthly]

Recruiting PHASE4

First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tata Main Hospital

Data source: Tata Main Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jamshedpur, India